Old Point Trust & Financial Services N A Ocuphire Pharma, Inc. Call Options Transaction History
Old Point Trust & Financial Services N A
- $269 Million
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding OCUP
# of Institutions
52Shares Held
3.42MCall Options Held
3.6KPut Options Held
6.2K-
Vanguard Group Inc Valley Forge, PA992KShares$1.55 Million0.0% of portfolio
-
Rice Hall James & Associates, LLC292KShares$455,4960.04% of portfolio
-
Geode Capital Management, LLC Boston, MA234KShares$365,6600.0% of portfolio
-
Richmond Brothers, Inc. Jackson, MI227KShares$354,8390.87% of portfolio
-
Mai Capital Management224KShares$349,3930.0% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $32.1M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...